A Multi-Center Prospective Study to Validate an Algorithm Using Urine and Plasma Biomarkers for Predicting Gleason ≥3+4 Prostate Cancer on Biopsy
Published in Seminars in Diagnostic Pathology, November 2017
Contact Us To Get Started!
Work with us – your premier oncology partner – to optimize cancer care for patients